Genomics

Dataset Information

0

Profiling hepatic microRNAs in zebrafish: Fluoxetine exposure mimics a fasting response that targets AMP-activated protein kinase (AMPK)


ABSTRACT: Recent evidence has suggested that fluoxetine, a serotonin-reuptake inhibitor and emerging environmental contaminant, can have non-targeted effects on metabolism in fish exposed to this waterborne pollutant. Using the highest, environmentally relevant, detectable level of fluoxetine (540 ng/L) we examined the impact of fluoxetine on the miRNA profile in the liver of zebrafish that were both fed and fasted for a period of 7 days. These results were further compared to the miRNA profile of zebrafish fasted and fed for 7 days, which were not exposed to fluoxetine. Results indicated that several miRNA that were involved with downregulating genes/pathways in response to fasting were also upregulated in fish exposed to fluoxetine, irrespective to fasting or feeding. These results suggest fluoxetine can have non-targeted effects on metabolic pathways mediated through miRNA expression. Furthermore, specific miRNA (dre-let-7d & dre-miR-140-5p) were found to target the catalytic subunit (AMPKa1 & AMPKa2, respectively) of AMP-Kinase, a master regulator of metabolism. Using predictive software and qPCR validation, combined with the expression profile of these two miRNA, we were able to establish a significant relationship between the expression of these specific miRNA to the downregulation of AMPKa subunit under the influence of 540 ng/L fluoxetine.

ORGANISM(S): Danio rerio

PROVIDER: GSE55229 | GEO | 2014/02/21

SECONDARY ACCESSION(S): PRJNA238932

REPOSITORIES: GEO

Similar Datasets

2014-02-21 | E-GEOD-55229 | biostudies-arrayexpress
2018-12-26 | GSE108436 | GEO
2018-12-26 | GSE108435 | GEO
2015-11-05 | E-GEOD-66257 | biostudies-arrayexpress
2023-02-24 | GSE225696 | GEO
2023-02-24 | GSE225695 | GEO
2015-11-07 | E-GEOD-74753 | biostudies-arrayexpress
2022-01-11 | PXD020983 | Pride
2017-01-12 | GSE84845 | GEO
2013-08-27 | GSE44839 | GEO